{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:37:28Z","timestamp":1790617048720,"version":"4.1.0"},"reference-count":45,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Pract Neurol"],"accepted":{"date-parts":[[2017,9,27]]},"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:p>Metabolic myopathies are a diverse group of rare genetic disorders and their associated muscle symptoms may be subtle. Patients may present with indolent myopathic features, exercise intolerance or recurrent rhabdomyolysis. Diagnostic delays are common and clinicians need a high index of suspicion to recognise and differentiate metabolic myopathies from other conditions that present in a similar fashion. Standard laboratory tests may be normal or non-specific, particularly between symptomatic episodes. Targeted enzyme activity measurement and next-generation genetic sequencing are increasingly used. There are now specific enzyme replacement therapies available, and other metabolic strategies and gene therapies are undergoing clinical trials. Here, we discuss our approach to the adult patient with suspected metabolic myopathy. We outline key features in the history and examination and discuss some mimics of metabolic myopathies. We highlight some disorders of glycogen and fatty acid utilisation that present in adulthood and outline current recommendations on management.<\/jats:p>","DOI":"10.1136\/practneurol-2017-001708","type":"journal-article","created":{"date-parts":[[2017,12,9]],"date-time":"2017-12-09T20:10:36Z","timestamp":1512850236000},"page":"14-26","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":57,"title":["Metabolic myopathies: a practical approach"],"prefix":"10.1136","volume":"18","author":[{"given":"James B","family":"Lilleker","sequence":"first","affiliation":[{"name":"Greater Manchester Neurosciences Centre, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann Shern","family":"Keh","sequence":"additional","affiliation":[{"name":"Greater Manchester Neurosciences Centre, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Roncaroli","sequence":"additional","affiliation":[{"name":"Greater Manchester Neurosciences Centre, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford, UK"},{"name":"Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Sharma","sequence":"additional","affiliation":[{"name":"The Mark Holland Metabolic Unit, Salford Royal NHS Foundation Trust, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Roberts","sequence":"additional","affiliation":[{"name":"Greater Manchester Neurosciences Centre, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,12,9]]},"reference":[{"key":"2025090410103405000_18.1.14.1","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/gim.2015.9","article-title":"Determining the prevalence of McArdle disease from gene frequency by analysis of next-generation sequencing data","volume":"17","author":"De Castro","year":"2015","journal-title":"Genet Med"},{"key":"2025090410103405000_18.1.14.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61555-X"},{"key":"2025090410103405000_18.1.14.3","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.76"},{"key":"2025090410103405000_18.1.14.4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1212\/WNL.0000000000002758","article-title":"Prevalence of Pompe disease in 3,076 patients with hyperCKemia and limb-girdle muscular weakness","volume":"87","author":"Lukacs","year":"2016","journal-title":"Neurology"},{"key":"2025090410103405000_18.1.14.5","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0390-6"},{"key":"2025090410103405000_18.1.14.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2012.04320.x"},{"key":"2025090410103405000_18.1.14.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsem-2016-000151"},{"key":"2025090410103405000_18.1.14.8","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0b013e3181903126"},{"key":"2025090410103405000_18.1.14.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0801327"},{"key":"2025090410103405000_18.1.14.10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1249\/JSR.0b013e3181fc6d1a","article-title":"An outbreak of muscle breakdown: a morality play in four acts","volume":"9","author":"Eichner","year":"2010","journal-title":"Curr Sports Med Rep"},{"key":"2025090410103405000_18.1.14.11","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2014-307663"},{"key":"2025090410103405000_18.1.14.12","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2009.195040"},{"key":"2025090410103405000_18.1.14.13","first-page":"377","article-title":"[Manifesting carriers of Duchenne muscular dystrophy over two generations]","volume":"33","author":"Itagaki","year":"1993","journal-title":"Rinsho Shinkeigaku"},{"key":"2025090410103405000_18.1.14.14","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000128"},{"key":"2025090410103405000_18.1.14.15","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.61.1.27"},{"key":"2025090410103405000_18.1.14.16","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000101"},{"key":"2025090410103405000_18.1.14.17","first-page":"S4","article-title":"Diagnosis of glycogenosis type II","volume":"71","author":"Bembi","year":"2008","journal-title":"Neurology"},{"key":"2025090410103405000_18.1.14.18","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2014-001031"},{"key":"2025090410103405000_18.1.14.19","first-page":"35","article-title":"Muscle glycogenoses: an overview","volume":"26","author":"Di Mauro","year":"2007","journal-title":"Acta Myol"},{"key":"2025090410103405000_18.1.14.20","doi-asserted-by":"publisher","DOI":"10.1002\/mus.1103"},{"key":"2025090410103405000_18.1.14.21","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.nmd.2017.04.013","article-title":"Misdiagnosis is an important factor for diagnostic delay in McArdle disease","volume":"27","author":"Scalco","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"2025090410103405000_18.1.14.22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1212\/WNL.62.1.82","article-title":"No spontaneous second wind in muscle phosphofructokinase deficiency","volume":"62","author":"Haller","year":"2004","journal-title":"Neurology"},{"key":"2025090410103405000_18.1.14.23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1056\/NEJM199102073240603","article-title":"Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency","volume":"324","author":"Haller","year":"1991","journal-title":"N Engl J Med"},{"key":"2025090410103405000_18.1.14.24","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10725"},{"key":"2025090410103405000_18.1.14.25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrneurol.2016.75","article-title":"Skeletal muscle disorders of glycogenolysis and glycolysis","volume":"12","author":"Godfrey","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"2025090410103405000_18.1.14.26","unstructured":"Mart\u00edn MA , Luc\u00eda A , Arenas J , et al . Glycogen storage disease type V. Seattle: University of Washington, 1993."},{"key":"2025090410103405000_18.1.14.27","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-006-0447-x"},{"key":"2025090410103405000_18.1.14.28","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2008.059469"},{"key":"2025090410103405000_18.1.14.29","doi-asserted-by":"crossref","unstructured":"Quinlivan R , Martinuzzi A , Schoser B . Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V). Quinlivan R , ed. Cochrane Database of Systematic Reviews. Chichester, UK, 2014. doi:10.1002\/14651858.CD003458.pub5","DOI":"10.1002\/14651858.CD003458.pub5"},{"key":"2025090410103405000_18.1.14.30","doi-asserted-by":"crossref","unstructured":"Quinlivan R , Vissing J , Hilton-Jones D , et al . Physical training for McArdle disease. Quinlivan R , ed. Cochrane database of systematic reviews. Chichester, UK: John Wiley & Sons, Ltd, 2011. doi:10.1002\/14651858.CD007931.pub2","DOI":"10.1002\/14651858.CD007931.pub2"},{"key":"2025090410103405000_18.1.14.31","unstructured":"Leslie N , Bailey L . Pompe Disease. Seattle: University of Washington, 1993."},{"key":"2025090410103405000_18.1.14.32","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000313367.09469.13"},{"key":"2025090410103405000_18.1.14.33","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/2013.jamaneurol.486","article-title":"Diagnosis of Pompe Disease","volume":"70","author":"Vissing","year":"2013","journal-title":"JAMA Neurol"},{"key":"2025090410103405000_18.1.14.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2006.02.035"},{"key":"2025090410103405000_18.1.14.35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909859"},{"key":"2025090410103405000_18.1.14.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2010.09.011"},{"key":"2025090410103405000_18.1.14.37","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/ene.13285","article-title":"European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience","volume":"24","author":"van der Ploeg","year":"2017","journal-title":"Eur J Neurol"},{"key":"2025090410103405000_18.1.14.38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ymgme.2016.01.013","article-title":"Observational clinical study of 22 adult-onset Pompe disease patients undergoing enzyme replacement therapy over 5years","volume":"117","author":"Stepien","year":"2016","journal-title":"Mol Genet Metab"},{"key":"2025090410103405000_18.1.14.39","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-010-0096-4"},{"key":"2025090410103405000_18.1.14.40","unstructured":"Wieser T . Carnitine Palmitoyltransferase II Deficiency. Seattle: University of Washington, 1993."},{"key":"2025090410103405000_18.1.14.41","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21167"},{"key":"2025090410103405000_18.1.14.42","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000078195.05396.20"},{"key":"2025090410103405000_18.1.14.43","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000118"},{"key":"2025090410103405000_18.1.14.44","unstructured":"Leslie ND , Valencia CA , Strauss AW , et al . In: Adam MP , Ardinger HH , Pagon RA , eds. Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency. Seattle (WA): GeneReviews, University of Washington, 2014."},{"key":"2025090410103405000_18.1.14.45","unstructured":"diMauro S , De Vivo DC . Basic Neurochemistry: Molecular, Cellular and Medical Aspects, sixth edition. Siegel GJ , Agranoff GJ , Albers GJ , et al . Diseases of Carbohydrate and Fatty Acid Metabolism in Muscle. Philadelphia: Lippincott-Raven, 1999."}],"container-title":["Practical Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/practneurol-2017-001708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T17:10:47Z","timestamp":1757005847000},"score":1,"resource":{"primary":{"URL":"https:\/\/pn.bmj.com\/lookup\/doi\/10.1136\/practneurol-2017-001708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,9]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,16]]},"published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1136\/practneurol-2017-001708"],"URL":"https:\/\/doi.org\/10.1136\/practneurol-2017-001708","relation":{},"ISSN":["1474-7758","1474-7766"],"issn-type":[{"value":"1474-7758","type":"print"},{"value":"1474-7766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,9]]}}}